Cipla's profit FY 2009-2019

In fiscal year 2019, the Indian pharmaceutical company, Cipla had a total profit of around 15 billion Indian rupees. This was comparable to the profits from fiscal year 2013, when the company saw the highest profit margins in the last ten years at 15.45 billion rupees.

Profit generated by Cipla Limited from financial year 2009 to 2019 (in billion Indian rupees)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2019

Region

India

Survey time period

FY 2009 to FY 2019

Special properties

Consolidated

Supplementary notes

*Profit after tax attributable to the shareholders according to source.

One Indian rupee is equal to 0.012 euros and 0.013 U.S. dollars (as of April 2020).

India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical brands: Humira (AbbVie)"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.